Jyoji Nakagawara Selected Research

iomazenil

1/2013	Cortical damage following traumatic brain injury evaluated by iomazenil SPECT and in vivo microdialysis.
1/2012	Diagnostic imaging of higher brain dysfunction in patients with adult moyamoya disease using statistical imaging analysis for [123I]iomazenil single photon emission computed tomography.
10/2010	Recovered neuronal viability revealed by Iodine-123-iomazenil SPECT following traumatic brain injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jyoji Nakagawara Research Topics

Disease

32	Stroke (Strokes) 06/2022 - 11/2009
16	Ischemic Stroke 01/2019 - 07/2006
15	Atrial Fibrillation 06/2022 - 01/2011
13	Hemorrhage 06/2022 - 03/2014
12	Cerebral Hemorrhage 01/2018 - 09/2009
8	Intracranial Hemorrhages (Intracranial Hemorrhage) 09/2015 - 03/2010
7	Embolism (Embolus) 06/2022 - 04/2012
4	Body Weight (Weight, Body) 06/2022 - 11/2014
3	Myocardial Infarction 06/2022 - 12/2019
3	Thromboembolism 04/2020 - 01/2012
3	Moyamoya Disease (Moya-Moya Disease) 01/2019 - 06/2004
3	Hematoma 01/2018 - 12/2012
3	Cerebral Infarction 01/2018 - 11/2006
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2013 - 03/2010
2	Hypertension (High Blood Pressure) 03/2020 - 01/2011
2	Infarction (Infarctions) 08/2016 - 01/2010
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2013 - 10/2010
2	Brain Ischemia (Cerebral Ischemia) 01/2012 - 06/2004
2	Hyperglycemia 01/2012 - 11/2009
1	Diabetes Mellitus 01/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Transient Ischemic Attack 01/2019
1	Inflammation (Inflammations) 12/2017
1	Dementia (Dementias) 12/2017
1	Brain Edema (Cerebral Edema) 09/2015
1	Nervous System Diseases (Neurological Disorders) 09/2014
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2014
1	Intracranial Vasospasm 02/2014
1	Brain Concussion (Cerebral Concussion) 01/2013
1	Wounds and Injuries (Trauma) 01/2013
1	Brain Infarction 09/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2011
1	Contusions 10/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2010
1	Anemia 04/2010
1	Hematuria 04/2010
1	Heart Failure 11/2009
1	Ischemia 06/2004

Drug/Important Bio-Agent (IBA)

20	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2014 - 07/2006
11	RivaroxabanIBA 06/2022 - 11/2014
9	AnticoagulantsIBA 04/2020 - 01/2012
7	CreatinineIBA 06/2022 - 01/2018
5	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 01/2012
5	Antihypertensive Agents (Antihypertensives)IBA 03/2014 - 09/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2015 - 04/2010
3	iomazenilIBA 01/2013 - 10/2010
2	Factor Xa InhibitorsIBA 07/2019 - 04/2012
2	Vitamin K FDA Link 01/2018 - 04/2012
2	Nicardipine (Dagan)FDA LinkGeneric 11/2014 - 12/2012
2	GABA-A Receptors (GABA(A) Receptor)IBA 01/2013 - 10/2010
1	Cytochrome P-450 CYP2C19IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Clopidogrel (Plavix)FDA Link 01/2019
1	Factor Xa (Coagulation Factor Xa)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 12/2017
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	Hemoglobins (Hemoglobin)IBA 08/2016
1	Desmodus rotundus salivary plasminogen activator alpha 1IBA 09/2015
1	Blood Glucose (Blood Sugar)IBA 03/2015
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2014
1	Oxygen (Dioxygen)IBA 09/2014
1	Eicosapentaenoic AcidIBA 02/2014
1	sphingosine phosphorylcholineIBA 02/2014
1	rho-Associated KinasesIBA 02/2014
1	MCOIBA 10/2013
1	Pharmaceutical PreparationsIBA 07/2013
1	Glucose (Dextrose)FDA LinkGeneric 04/2013
1	thiamine triphosphorate (TTP)IBA 01/2013
1	Dabigatran FDA Link 04/2012
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2012
1	LipidsIBA 01/2012
1	BenzodiazepinesIBA 01/2012
1	acceleratory factor from growth hormone (AcG)IBA 01/2012
1	candesartanIBA 09/2011
1	candesartan cilexetil (Amias)FDA Link 09/2011
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2011
1	Inosine Monophosphate (IMP)IBA 06/2004
1	Acetazolamide (Diamox)FDA LinkGeneric 06/2004

Therapy/Procedure

17	Therapeutics 01/2018 - 01/2011
2	Aftercare (After-Treatment) 03/2010 - 01/2010
1	Length of Stay 01/2018
1	Intravenous Administration 01/2013
1	Secondary Prevention 09/2011
1	Blood Transfusion (Blood Transfusions) 04/2010
1	Decompression 01/2010
1	Thrombolytic Therapy 11/2006